nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ADRA2C—attention deficit hyperactivity disorder	0.595	0.701	CbGaD
Dipivefrin—ADRA2A—attention deficit hyperactivity disorder	0.254	0.299	CbGaD
Dipivefrin—Epinephrine—ADRA2C—attention deficit hyperactivity disorder	0.00248	0.701	CrCbGaD
Dipivefrin—Epinephrine—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.299	CrCbGaD
Dipivefrin—ACHE—midbrain—attention deficit hyperactivity disorder	0.000439	0.0746	CbGeAlD
Dipivefrin—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000368	0.0625	CbGeAlD
Dipivefrin—ACHE—cerebellum—attention deficit hyperactivity disorder	0.00034	0.0577	CbGeAlD
Dipivefrin—BCHE—forebrain—attention deficit hyperactivity disorder	0.000327	0.0555	CbGeAlD
Dipivefrin—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000311	0.0528	CbGeAlD
Dipivefrin—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000279	0.0475	CbGeAlD
Dipivefrin—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.000276	0.047	CbGeAlD
Dipivefrin—ACHE—brain—attention deficit hyperactivity disorder	0.000276	0.0469	CbGeAlD
Dipivefrin—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000231	0.0393	CbGeAlD
Dipivefrin—BCHE—midbrain—attention deficit hyperactivity disorder	0.000216	0.0367	CbGeAlD
Dipivefrin—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.0002	0.0339	CbGeAlD
Dipivefrin—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000192	0.0326	CbGeAlD
Dipivefrin—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.00019	0.0323	CbGeAlD
Dipivefrin—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000188	0.0319	CbGeAlD
Dipivefrin—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000185	0.0314	CbGeAlD
Dipivefrin—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000183	0.0311	CbGeAlD
Dipivefrin—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000179	0.0304	CbGeAlD
Dipivefrin—BCHE—nervous system—attention deficit hyperactivity disorder	0.000177	0.0301	CbGeAlD
Dipivefrin—BCHE—central nervous system—attention deficit hyperactivity disorder	0.000171	0.029	CbGeAlD
Dipivefrin—BCHE—cerebellum—attention deficit hyperactivity disorder	0.000167	0.0284	CbGeAlD
Dipivefrin—ADRA1A—brain—attention deficit hyperactivity disorder	0.000152	0.0259	CbGeAlD
Dipivefrin—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000152	0.0258	CbGeAlD
Dipivefrin—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000146	0.0248	CbGeAlD
Dipivefrin—ADRA2C—brain—attention deficit hyperactivity disorder	0.000145	0.0247	CbGeAlD
Dipivefrin—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000143	0.0243	CbGeAlD
Dipivefrin—BCHE—brain—attention deficit hyperactivity disorder	0.000136	0.023	CbGeAlD
Dipivefrin—ADRA2A—brain—attention deficit hyperactivity disorder	0.000116	0.0197	CbGeAlD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	6.86e-05	0.000483	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.8e-05	0.000478	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.77e-05	0.000476	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.68e-05	0.00047	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.68e-05	0.00047	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.68e-05	0.00047	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	6.68e-05	0.00047	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.66e-05	0.000469	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	6.66e-05	0.000468	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.64e-05	0.000467	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	6.64e-05	0.000467	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.61e-05	0.000465	CbGpPWpGaD
Dipivefrin—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.6e-05	0.000464	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.6e-05	0.000464	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.53e-05	0.000459	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.48e-05	0.000456	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.43e-05	0.000452	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.39e-05	0.00045	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.32e-05	0.000445	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	6.31e-05	0.000444	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.24e-05	0.000439	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.24e-05	0.000439	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.24e-05	0.000439	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.23e-05	0.000438	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	6.2e-05	0.000436	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.15e-05	0.000432	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	6.05e-05	0.000426	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.05e-05	0.000426	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.94e-05	0.000418	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.82e-05	0.00041	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.82e-05	0.00041	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.81e-05	0.000409	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.8e-05	0.000408	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	5.8e-05	0.000408	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.75e-05	0.000404	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.73e-05	0.000403	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.65e-05	0.000398	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	5.65e-05	0.000398	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.63e-05	0.000396	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.62e-05	0.000396	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.52e-05	0.000389	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.52e-05	0.000389	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.46e-05	0.000384	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.46e-05	0.000384	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.44e-05	0.000383	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	5.43e-05	0.000382	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.41e-05	0.000381	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.4e-05	0.00038	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.39e-05	0.000379	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.35e-05	0.000376	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.29e-05	0.000372	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.22e-05	0.000367	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.08e-05	0.000358	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.07e-05	0.000357	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.07e-05	0.000357	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.02e-05	0.000353	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.02e-05	0.000353	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.94e-05	0.000348	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.91e-05	0.000346	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.88e-05	0.000343	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.75e-05	0.000335	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.72e-05	0.000332	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.68e-05	0.000329	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.62e-05	0.000325	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.54e-05	0.00032	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.49e-05	0.000316	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.49e-05	0.000316	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.43e-05	0.000312	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.42e-05	0.000311	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.36e-05	0.000307	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.34e-05	0.000306	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.32e-05	0.000304	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.3e-05	0.000303	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.27e-05	0.0003	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.25e-05	0.000299	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.19e-05	0.000295	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.07e-05	0.000287	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.04e-05	0.000284	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.04e-05	0.000284	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.02e-05	0.000283	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.97e-05	0.000279	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.92e-05	0.000276	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.9e-05	0.000275	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.89e-05	0.000274	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	3.89e-05	0.000273	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.89e-05	0.000273	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.87e-05	0.000273	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.85e-05	0.000271	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.84e-05	0.00027	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.83e-05	0.000269	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.82e-05	0.000269	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	3.82e-05	0.000269	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.78e-05	0.000266	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.78e-05	0.000266	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.77e-05	0.000266	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.75e-05	0.000264	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.75e-05	0.000264	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.75e-05	0.000264	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.73e-05	0.000262	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.71e-05	0.000261	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.7e-05	0.000261	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.67e-05	0.000258	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.66e-05	0.000258	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.65e-05	0.000257	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.63e-05	0.000256	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.6e-05	0.000253	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.57e-05	0.000251	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.57e-05	0.000251	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.56e-05	0.000251	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.55e-05	0.00025	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.54e-05	0.000249	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.53e-05	0.000249	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.53e-05	0.000248	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.53e-05	0.000248	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.52e-05	0.000248	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.5e-05	0.000247	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.49e-05	0.000245	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.47e-05	0.000244	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.47e-05	0.000244	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	3.47e-05	0.000244	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.47e-05	0.000244	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.45e-05	0.000243	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.43e-05	0.000241	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.43e-05	0.000241	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	3.41e-05	0.00024	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.41e-05	0.00024	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.41e-05	0.00024	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.39e-05	0.000238	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.31e-05	0.000233	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.3e-05	0.000232	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.29e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.28e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.28e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.24e-05	0.000228	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.2e-05	0.000225	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.2e-05	0.000225	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.19e-05	0.000225	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.19e-05	0.000224	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.18e-05	0.000224	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.17e-05	0.000223	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.15e-05	0.000222	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.12e-05	0.00022	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.12e-05	0.00022	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.11e-05	0.000219	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.08e-05	0.000217	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.06e-05	0.000216	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.05e-05	0.000214	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	3.01e-05	0.000212	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.01e-05	0.000212	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.98e-05	0.00021	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.98e-05	0.00021	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.98e-05	0.000209	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.96e-05	0.000208	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	2.96e-05	0.000208	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.96e-05	0.000208	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.95e-05	0.000208	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.9e-05	0.000204	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.88e-05	0.000203	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.87e-05	0.000202	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.87e-05	0.000202	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.85e-05	0.0002	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.84e-05	0.0002	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.8e-05	0.000197	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.77e-05	0.000195	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.77e-05	0.000195	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.75e-05	0.000194	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.68e-05	0.000189	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.67e-05	0.000188	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.65e-05	0.000187	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.64e-05	0.000186	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.62e-05	0.000184	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.61e-05	0.000184	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.6e-05	0.000183	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.48e-05	0.000174	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.46e-05	0.000173	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.45e-05	0.000172	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.45e-05	0.000172	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.43e-05	0.000171	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.42e-05	0.000171	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.41e-05	0.000169	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.41e-05	0.000169	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	2.35e-05	0.000166	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	2.34e-05	0.000164	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.32e-05	0.000163	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.3e-05	0.000162	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.29e-05	0.000161	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.29e-05	0.000161	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.27e-05	0.000159	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.24e-05	0.000157	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.24e-05	0.000157	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.21e-05	0.000155	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.17e-05	0.000152	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.16e-05	0.000152	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.15e-05	0.000152	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.13e-05	0.00015	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	2.1e-05	0.000148	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	2.07e-05	0.000145	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.06e-05	0.000145	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.05e-05	0.000144	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.03e-05	0.000143	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000142	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.02e-05	0.000142	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.01e-05	0.000142	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.01e-05	0.000142	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.01e-05	0.000142	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2e-05	0.000141	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.96e-05	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.95e-05	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	1.93e-05	0.000136	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.92e-05	0.000135	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.87e-05	0.000132	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.86e-05	0.000131	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.83e-05	0.000129	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	1.82e-05	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	1.81e-05	0.000127	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.76e-05	0.000124	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.76e-05	0.000124	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.76e-05	0.000124	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.7e-05	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.7e-05	0.000119	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.67e-05	0.000118	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.65e-05	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.63e-05	0.000115	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.58e-05	0.000111	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.57e-05	0.00011	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.54e-05	0.000108	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.54e-05	0.000108	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.48e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.47e-05	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.43e-05	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.32e-05	9.3e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.3e-05	9.18e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.23e-05	8.69e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.08e-05	7.59e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	1.01e-05	7.1e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1e-05	7.06e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	9.01e-06	6.34e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	7.82e-06	5.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7e-06	4.93e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.91e-06	4.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.54e-06	4.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	6.35e-06	4.47e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.72e-06	4.02e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.31e-06	3.74e-05	CbGpPWpGaD
